CEO Göran Forsberg interviewed on new results with CAN10 and external validation of IL-1 blockade during inflammatory disease
Watch the interview in Swedish hereRedeye interviews CEO Göran Forsberg about new results on nadunolimab and alleviation of neuropathy during chemotherapy
Watch the interview in Swedish hereCEO Göran Forsberg presents at Redeye Fight Cancer Event 2024
Watch the presentation here(R) = Regulatory press releases